A clinical trial to assess biomarker modulation by tamoxifen in normal and premalignant breast tissue

Medicine and Dentistry

• Tamoxifen 100%
• Biological Marker 83%
• Breast Tissue 50%
• Patient 50%
• Follow up 33%
• Hyperplasia 33%
• Analysis 33%
• Woman 33%
• Biopsy 33%
• Diseases 16%
• Phenotype 16%
• Mammography 16%
• Needle Biopsy 16%
• Breast Cancer Prevention 16%
• Mortality 16%
• Atypical Ductal Hyperplasia 16%
• Breast Epithelium 16%
• Arm 16%
• Tissues 16%
• Observation 16%
• Incidence 16%
• Breast 16%
• Hispanic 16%
• Indicator 16%

Biochemistry, Genetics and Molecular Biology

• Bcl-2 33%
• Clinical Trial 33%
• Modulation 16%
• Phenotype 16%
• Time 16%
• Sample 16%
• Incidence 16%
• Mortality 16%